These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11966641)

  • 61. Novel endoscopic diagnosis for bladder cancer.
    Lerner SP; Goh A
    Cancer; 2015 Jan; 121(2):169-78. PubMed ID: 25132313
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Urinary cytology for carcinoma of the urinary bladder].
    Nagumo S; Matuda M; Kuroda M
    Rinsho Byori; 1992 Jul; 40(7):728-35. PubMed ID: 1507491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.
    Isfoss BL
    BJU Int; 2011 Dec; 108(11):1703-7. PubMed ID: 21777364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
    Loidl W; Schmidbauer J; Susani M; Marberger M
    Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist!
    Jichlinski P; Leisinger HJ
    Urol Int; 2005; 74(2):97-101. PubMed ID: 15756058
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Determination of hypericin in human plasma by high-performance liquid chromatography after intravesical administration in patients with transitional cell carcinoma of the bladder.
    Kamuhabwa AA; Di Mavungu JD; Baert L; D'Hallewin MA; Hoogmartens J; de Witte PA
    Eur J Pharm Biopharm; 2005 Apr; 59(3):469-74. PubMed ID: 15760727
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fluorescence cytology of the urinary bladder.
    Tauber S; Schneede P; Liedl B; Liesmann F; Zaak D; Hofstetter A
    Urology; 2003 May; 61(5):1067-71. PubMed ID: 12736049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over.
    Soria F; Gurioli A; Peraldo F; Oderda M; Giona S; Ambrosini E; Frea B; Gontero P
    Urologia; 2013 Jun; 80 Spec No 1():1-8. PubMed ID: 23813287
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
    Kamuhabwa AA; Huygens A; De Witte PA
    Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Usefulness of endoscopic evaluation with fluorescence after endovesical BCG in the management of non-invasive bladder tumors].
    Charbit D; Arnoux V; Gobet F; Pasquier D; Descotes JL; Pfister C
    Prog Urol; 2014 Jul; 24(9):551-5. PubMed ID: 24975789
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer.
    Trott PA; Edwards L
    J Urol; 1973 Dec; 110(6):664-6. PubMed ID: 4757548
    [No Abstract]   [Full Text] [Related]  

  • 73. Selective surface staining of bladder tumors by intravesical methylene blue with enhanced endoscopic identification.
    Gill WB; Huffman JL; Lyon ES; Bagley DH; Schoenberg HW; Straus FH
    Cancer; 1984 Jun; 53(12):2724-7. PubMed ID: 6202385
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms.
    Jeon SS; Kang I; Hong JH; Choi HY; Chai SE
    J Endourol; 2001 Sep; 15(7):753-9. PubMed ID: 11697410
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.
    Zaak D; Karl A; Knüchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C
    BJU Int; 2005 Aug; 96(2):217-22. PubMed ID: 16001963
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinically occult bladder cancer diagnosis. Trial using ultraviolet cystoscopy.
    Devonec M; Lenz P; Bouvier R; Blanc-Brunat N; Dubernard JM
    Cancer; 1985 Jan; 55(2):468-71. PubMed ID: 2578087
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of bladder dysplasia using 5-aminolaevulinic acid-induced porphyrin fluorescence.
    Landry JL; Gelet A; Bouvier R; Dubernard JM; Martin X; Colombel M
    BJU Int; 2003 May; 91(7):623-6. PubMed ID: 12699472
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
    Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
    Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vivo staining test with methylene blue for bladder cancer.
    Fukui I; Yokokawa M; Mitani G; Ohwada F; Wakui M; Washizuka M; Tohma T; Igarashi K; Yamada T
    J Urol; 1983 Aug; 130(2):252-5. PubMed ID: 6192250
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnosing the location of carcinoma in situ (CIS) of the urinary bladder using pirarubicin hydrochloride.
    Uchikoba T; Horiuchi K; Oka F; Sato M; Tsuboi N; Ohaki Y; Nishimura T
    Urol Int; 2005; 74(3):235-9. PubMed ID: 15812210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.